Semaglutide drugs like Ozempic and Wegovy are transforming obesity treatment, but questions remain about long-term safety, access, and societal impact.
New anti-obesity medications are transforming weight management, challenging old paradigms, and raising new questions about the future of dieting and health.
Scientists at KAIST have identified a unique gut-brain pathway that enables the brain to distinguish glucose from other nutrients, paving the way for novel treatments for metabolic disorders.